NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/30/2024
Back to search
Official data from USPTO
FLUOTAG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
09/30/2024
Trademark type
Combined
Nice classes
1, 5
Filing date
03/15/2017
Registration date
04/10/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/30/2024
Last transaction
09/30/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Goettingen, DE
Examiner
LOTT, MAUREEN DALL
Current location
Historical data usage
Mark description
The mark consists of the literal element "FluoTag" in stylized letters, with "F" and "T" capitalized.
Holders and representatives
Holders
NanoTag Biotechnologies GmbH
Representatives
Ryan D. Artis RIVERSIDE LAW LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents for scientific or industrial purposes and not for medical or veterinary usechemical reagents containing antibodies or proteins having antibody-like properties; Chemical reagents for scientific or industrial purposes and not for medical or veterinary usefor microscopyflow cytometrywestern blotimagingfluorescence based analysistissue analysis; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents containing antibodies or proteins having antibody-like properties; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents for microscopyflow cytometrywestern blotimagingfluorescence based analysistissue analysis
Class 5
Pharmaceutical and veterinary preparations containing antibodiesall for use in treating cancer; Pharmaceutical and veterinary preparations containing antibodiesall for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing antibodiesall for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing antibodiesall for use in treating inflammatory diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating cancer; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating inflammatory diseases; Diagnostic preparations for medical or veterinary purposesnamely preparations containing antibodies or proteins having antibody-like properties ; Drugs being pharmaceutical preparations containing antibodiesall for use in treating cancer; Drugs being pharmaceutical preparations containing antibodiesall for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing antibodiesall for use in treating infectious diseases; Drugs being pharmaceutical preparations containing antibodiesall for use in treating inflammatory diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating cancer; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating infectious diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating inflammatory diseases; Vaccines containing antibodies; Vaccines containing proteins having antibody-like properties
Publications
History of USPTO decisions and trademark events.
19 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/30/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/26/2024
E815
TEAS SECTION 8 & 15 RECEIVED
03/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2018
PUBO
PUBLISHED FOR OPPOSITION
01/23/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/07/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/09/2017
GNRT
NON-FINAL ACTION E-MAILED
06/09/2017
CNRT
NON-FINAL ACTION WRITTEN
06/09/2017
DOCK
ASSIGNED TO EXAMINER
06/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2017
NWAP
NEW APPLICATION ENTERED
03/18/2017
Continuous trademark protection
Get notified about every new filing that threatens FLUOTAG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.